COMMUNIQUÉS West-GlobeNewswire

Correction: Transactions of Managers and Closely Associated Persons
07/01/2026
Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons. ATP Holdings ehf. announced two [...]
LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates
07/01/2026
Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-November 2025 Achieved approximately $1.6 million in net product revenue with [...]
Range Impact Announces Two Major Land Acquisitions in Kentucky and Sale of Abandoned Mine Land Services Business
07/01/2026
CLEVELAND, OHIO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed coal mine properties [...]
Neocis Surpasses 100,000 Robotic Osteotomies with the Yomi Platform
07/01/2026
Landmark milestone demonstrates proven robotic adoption as the next generation Yomi S completes the first real world cases MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Neocis, the market leader behind the Yomi® robotic [...]
National Institutes of Health Awards $1.54M Grant To Scottish Rite for Children for Rare Diseases Research
07/01/2026
Promising Hydrogel Could Help Kids Walk Again and Adults Avoid Invasive Surgery Dallas, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Every year, thousands of children and adults face the crippling effects of osteonecrosis. Now, [...]
GENFIT annonce son calendrier financier pour 2026
07/01/2026
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 7 janvier 2026 – GENFIT (Euronext : GNFT) , société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des [...]
GENFIT Announces 2026 Financial Calendar
07/01/2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 7, 2026 - GENFIT (Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare [...]
Comprehensive Healthcare Welcomes Community Behavioral Health Veteran as Chief Medical Officer
07/01/2026
YAKIMA, Wash., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare, the leading community behavioral health provider in Central and Southwest Washington, is proud to welcome Mark Bradshaw, M.D., as its new chief [...]
AB Science annonce un quatrième cas consécutif de réponse avec la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute, sur la base des données de phase 1
07/01/2026
COMMUNIQUÉ DE PRESSE AB SCIENCE ANNONCE UN QUATRIÈME CAS CONSÉCUTIF DE RÉPONSE AVEC LA COMBINAISON D’AB8939 ET DU VENETOCLAX DANS LE TRAITEMENT DE LA LEUCÉMIE MYÉLOÏDE AIGUË RÉFRACTAIRE OU EN RECHUTE, SUR LA BASE DES [...]
AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
07/01/2026
PRESS RELEASE AB SCIENCE REPORTS FOURTH CONSECUTIVE CASE OF RESPONSE FROM PHASE 1 DATA FOR THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA The combination [...]
300 Exceptional Teen Scientists Recognized for Innovative STEM Research in Nation’s Oldest and Most Prestigious High School Competition
07/01/2026
Regeneron Science Talent Search Marks Milestone 85th Year with $1.2 Million Awarded to Nation’s Most Promising Young Scientists and Their Schools WASHINGTON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Society for Science (the [...]
Ipsen - Décembre 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
07/01/2026
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Ipsen - December 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
07/01/2026
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease
07/01/2026
Herantis Pharma Plc – Company release Inside information: Herantis Pharma – Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease Biomarker data show that HER- [...]
Ottimo Pharma Announces FDA Clearance of Investigational New Drug (IND) Application for OTP-01, a First-in-Class, Dual-Paratopic, Single-Agent, Anti-PD-1/VEGFR2 Antibody
07/01/2026
First patient dosed and study open in leading oncology centers in US and Australia Phase I/IIA adaptive study aims to assess and optimize the dose of OTP-01 and provide safety, tolerability, and early efficacy data [...]
Koelis Announces Designated CPT I Codes for Fusion Biopsy and Transperineal Biopsy in Prostate Cancer Diagnosis
07/01/2026
GRENOBLE, France and PRINCETON, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com ), a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer [...]
HyperCharge Health issues new statement calling for increased attention on Minnesota's Lyme Disease Crisis
07/01/2026
MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- HyperCharge Health is calling on media outlets to help shine a light on this overlooked public health issue and amplify the voices of patients who have gone unheard for far [...]
Protara Therapeutics Announces Dosing of First Patient in Phase 3 Registrational THRIVE-3 Trial of IV Choline Chloride in Patients on Long-Term Parenteral Support
07/01/2026
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that [...]
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
07/01/2026
SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced that Nancy [...]

Pages